Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2024 ∙ Kechagias, K. S. Laleye, J. D. Drmota, J. Geropoulos, G. Kyrtsonis, G. Zafeiri, M. Triantafyllidis, K. K. Stathi, D.
Minimal change disease following COVID-19 vaccination: A systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Louw, G. E. Hohlfeld, A. S. J. Kalan, R. Engel, M. E.
Mobile Phone Text Message Reminders to Improve Vaccination Uptake: A Systematic Review and Meta-Analysis
Parents/caregivers Children Adolescents Adults Coverage
Rating:
Not applicable
2024 ∙ Rachelle, H. Malak, G. Houry, P. Marc, H. Sacha, S. Yara, G. Joseph, E. B. Anthony, Y. Ghinwa, H. Celine, M. Dima, I. Elias, A. K. Ola, E. Z. Assem, K. Marlene, C. Christos, M.
Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Eslami, A. Alimoghadam, S. Khoshravesh, S. Shirani, M. Alimoghadam, R. Alavi Darazam, I.
Mpox vaccination and treatment: a systematic review
All age groups Mpox Administration Efficacy/effectiveness
Rating:
Low
2024 ∙ Mektebi, A. Elsaid, M. Yadav, T. Abdallh, F. Assker, M. Siddiq, A. Sayad, R. Saifi, M. Farahat, R. A.
Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis
Healthcare workers Mpox Acceptance
Rating:
Not applicable
2024 ∙ Mason, L. M. K. Betancur, E. Riera-Montes, M. Lienert, F. Scheele, S.
MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings
All age groups Mpox Efficacy/effectiveness
Rating:
Low
2024 ∙ Choi, Y. Lee, J. S. Choe, Y. J. Lee, H. Yoon, Y. Shin, S. H. Hwang, M. J. Choi, H. Na, S. Kim, J. H. Kang, H. M. Ahn, B. Seo, K. Park, S.
Myocarditis and Pericarditis are Temporally Associated with BNT162b2 COVID-19 Vaccine in Adolescents: A Systematic Review and Meta-analysis
Newborn Children Adolescents COVID-19 Safety
Rating:
Critically low
2024 ∙ Ling, R. R. Grignani, R. Ling, M. R. Thenpandiyan, A. A. Tai, B. C. Somani, J. Ramanathan, K. Quek, S. C.
Myopericarditis following COVID-19 vaccination in children: a systematic review and meta-analysis
Children Adolescents COVID-19 Safety
Rating:
Moderate
2024 ∙ Oliveira, J. A. Silva, E. G. Karasu, A. F. G. Silva, A. M. N. Philip, C. E.
Neonatal and Maternal Outcomes of mRNA Compared With Non-mRNA Vaccinations in Pregnant Patients With COVID-19: A Systematic Review and Meta-Analysis
Pregnant women COVID-19 Efficacy/effectiveness Safety
Rating:
Low
2024 ∙ Mashkoor, Y. Nadeem, A. Fatima, T. Aamir, M. Vohra, L. I. Habib, A. Khan, A. Raufi, N. Habte, A.
Neurological complications of influenza vaccination: Navigating the spectrum with a focus on acute disseminated encephalomyelitis (ADEM)
Children Adolescents Adults Older adults Influenza Safety
Rating:
Low
Loading...